BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 4, 2019
Company News

BMS deal weighs on Celgene partners

BioCentury | Jan 4, 2019
Company News

BMS deal weighs on Celgene partners

BioCentury | Aug 4, 2014
Clinical News

Sotatercept: Additional Phase II data

BioCentury | Jun 23, 2014
Product Development

Battling beta T

Acceleron/Celgene, bluebird programs may suit different beta thalassemia patients
BioCentury | May 5, 2014
Clinical News

Sotatercept: Additional Phase IIa data

BioCentury | Apr 7, 2014
Company News

Acceleron, Celgene deal

BioCentury | Apr 7, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Apr 3, 2014
Financial News

Celgene increasing Acceleron stake

BioCentury | Mar 24, 2014
Clinical News

Sotatercept: Interim Phase II data

BioCentury | Feb 3, 2014
Finance

Financing frenzy

2014 biotech follow-ons off to second-fastest start in nearly 20 years
Items per page:
1 - 10 of 53